L-carnitine is one of 574 small molecule programs targeting Fatigue. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
2828 competitors in Breast Cancer
L-carnitine
Nolvadex
Megace
Lexiscan
Adenocard
Lupron
Recentin
Sporanox
Tricor
Zoladex
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details